Semaglutide and phentermine-topiramate are effective weight reducing medications
1. GLP-1 receptor agonists, such as semaglutide, and phentermine-topiramate were shown to cause the greatest percent decrease in body weight. ...
Tag: semaglutide
#VisualAbstract: Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials
1. Semaglutide 2.4 mg combined with once weekly cagrilintide therapy was not associated with increase in adverse events compared to ...
Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials
1. Semaglutide 2.4 mg combined with once weekly cagrilintide therapy was not associated with increase in adverse events compared to ...
#VisualAbstract: Semaglutide 2.4 mg once a week decreases bodyweight in overweight or obese patients with type 2 diabetes
1. Change in mean bodyweight was -9.6% with semaglutide 2.4 mg vs. -3.4% with placebo. 2. Approximately two-thirds of patients on ...
Semaglutide 2.4 mg once a week decreases bodyweight in overweight or obese patients with type 2 diabetes
1. Change in mean bodyweight was -9.6% with semaglutide 2.4 mg vs. -3.4% with placebo. 2. Approximately two-thirds of patients ...
Weekly semaglutide effective for decreasing body weight in obesity
1. Once-weekly treatment of semaglutide was associated with meaningful body weight reduction at 68 weeks compared to placebo in patients ...
Semaglutide associated with dose-dependent weight loss and resolution of nonalcoholic steatohepatitis
1. Nonalcoholic steatohepatitis (NASH) resolution without worsening of fibrosis occurred in a significantly greater percentage of patients who received semaglutide ...
The PIONEER 6 trial: semaglutide in type 2 diabetic patients does not increase cardiovascular risk
1. Over a median period of almost 16 months, type 2 diabetic (T2DM) patients randomized to oral semaglutide for experienced ...